antiretroviral therapies Press Release

Title Picture
06/11/2018 - 17:20
Americares Honors Mylan with Power of Partnership Award
Mylan's picture
Mylan
06/11/2018 - 16:56
Americares President and CEO Michael J. Nyenhuis (middle) presents the Power of Partnership Award to Mylan at the HDA Business and Leadership
Americares's picture
Americares
06/04/2018 - 01:49
U.S. FDA Approves Mylan and Biocon's Fulphila (pegfilgrastim-jmdb), the First Biosimilar to Neulasta
Mylan's picture
Mylan
04/25/2018 - 08:30
Mylan Adds to Growing Women's Healthcare Portfolio with Launch of Generic for Oral Contraceptive Yaz
Mylan's picture
Mylan
04/21/2018 - 11:08
Mylan Presents Equivalence Data on Glatiramer Acetate Compared to Copaxone at American Academy of Neurology 70th Annual Meeting
Mylan's picture
Mylan
04/11/2018 - 11:19
Mylan to Leverage its World-Class Scientific Platform to Develop a Novel Delivery for Meloxicam, a Non-Opioid Pain Medication
Mylan's picture
Mylan
04/11/2018 - 09:28
Investor Day Highlights Durability of Mylan's Global Platform
Mylan's picture
Mylan
04/11/2018 - 07:00
Mylan Partners with Fujifilm Kyowa Kirin Biologics to Commercialize Biosimilar to Humira (adalimumab)
Mylan's picture
Mylan
04/10/2018 - 05:39
Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma
Mylan's picture
Mylan
04/06/2018 - 03:19
Mylan Strengthens Its Capital Structure by Extending Its Debt Maturities with a Successful $1.5 Billion Bond Offering
Mylan's picture
Mylan
03/27/2018 - 00:29
Mylan and Biocon Receive Approvals from the European Commission and TGA Australia for Semglee, Biosimilar Insulin Glargine
Mylan's picture
Mylan
03/20/2018 - 05:06
Mylan Adds to Growing Oncology Portfolio with Launch of Generic Mutamycin Injection
Mylan's picture
Mylan
03/02/2018 - 10:04
Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.
Mylan's picture
Mylan
02/28/2018 - 16:39
Mylan to Bring a Biosimilar of BOTOX to the Market Through a Collaboration and License agreement with Revance Therapeutics
Mylan's picture
Mylan
02/20/2018 - 09:48
Mylan Receives Tentative Approval for Combination HIV Treatment DTG/FTC/TAF Under FDA's PEPFAR Program
Mylan's picture
Mylan
01/29/2018 - 07:07
Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Mylan's picture
Mylan
01/29/2018 - 04:23
Mylan and Biocon Receive Positive CHMP Opinion for Semglee, Biosimilar Insulin Glargine
Mylan's picture
Mylan
01/03/2018 - 14:39
Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEA (aflibercept)
Momenta's picture
Momenta
12/29/2017 - 00:10
Biocon and Mylan's Biosimilar Trastuzumab Receives Approval from ANVISA, Brazil Through their Partner Libbs
Mylan's picture
Mylan
12/11/2017 - 12:37
Teva Dismisses Litigation After Mylan Wins U.S. Court Ruling Related to Teva's Cold Filtration Patents for Copaxone 40 mg/mL
Mylan's picture
Mylan
12/04/2017 - 06:43
Mylan and Aspen Announce Launch of Generic Busulfex Injection
Mylan's picture
Mylan
12/01/2017 - 08:54
U.S. FDA Approves Mylan and Biocon's Ogivri, the First Biosimilar for Trastuzumab, for the Treatment of HER2-Positive Breast and Gastric Cancers
Mylan's picture
Mylan
11/30/2017 - 12:57
European Medicines Agency Accepts Marketing Authorization Applications for Mylan and Biocon's Proposed Biosimilars Trastuzumab and Pegfilgrastim
Mylan's picture
Mylan
11/13/2017 - 10:12
Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Mylan's picture
Mylan
11/09/2017 - 06:06
Mylan Launches Generic Clolar for Injection
Mylan's picture
Mylan
11/01/2017 - 06:36
Momenta and Mylan Report Initial Results from Phase 1 Clinical Trial for M834, a Proposed Biosimilar of ORENCIA (abatacept)
Momenta's picture
Momenta
10/27/2017 - 15:39
Mylan's EpiPen4Schools Program Surpasses One Million Free Epinephrine Auto-Injector Donations to U.S. Schools
Mylan's picture
Mylan
10/26/2017 - 07:51
Mylan Wins UK Court Ruling Related to Copaxone 40 mg/mL Patent
Mylan's picture
Mylan
10/05/2017 - 12:39
Mylan, in Partnership with Synthon, Receives Marketing Authorization Approval in Europe for First Generic for Copaxone 40 mg/mL
Mylan's picture
Mylan
10/03/2017 - 18:55
Mylan Confirms U.S. Launch of First Generic for Copaxone 40 mg/mL 3-Times-a-Week and Generic for Copaxone 20 mg/mL Once-Daily
Mylan's picture
Mylan
10/03/2017 - 16:44
Mylan Announces U.S. FDA Approval of First Generic for Copaxone 40 mg/mL 3-Times-a-Week and May Be Eligible for 180-Day Exclusivity
Mylan's picture
Mylan
10/02/2017 - 15:09
Mylan Launches Generic Cancidas for Injection
Mylan's picture
Mylan
09/29/2017 - 12:53
Mylan Launches Generic Gleevec Tablets
Mylan's picture
Mylan
09/14/2017 - 10:06
Mylan Expands Women's Healthcare Portfolio with Launch of Generic Minastrin 24 FE Tablets
Mylan's picture
Mylan
09/08/2017 - 12:37
Mylan Statement on Warning Letter Issued to Pfizers EpiPen Auto-Injector Manufacturing Site
Mylan's picture
Mylan
08/24/2017 - 03:31
Otsuka and Mylan Announce License Agreement to Commercialize Delamanid (Deltyba) for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries
Mylan's picture
Mylan
08/17/2017 - 08:36
Mylan Finalizes Settlement Agreement on Medicaid Rebate Classification for EpiPen Auto-Injector
Mylan's picture
Mylan
08/10/2017 - 04:36
Mylan Advances Access in the Fight Against HIV with the Launch of Three Generic Antiretroviral Medicines in Canada
Mylan's picture
Mylan
08/07/2017 - 21:51
Mylan Launches Avonza in India
Mylan's picture
Mylan
08/07/2017 - 03:54
Mylan Receives Tentative Approval for "TLD" Under PEPFAR
Mylan's picture
Mylan
07/26/2017 - 10:38
Mylan Receives WHO Prequalification for Generic Sovaldi
Mylan's picture
Mylan
07/24/2017 - 09:39
Drug interaction concerns may negatively affect HIV treatment adherence among transgender women
National Institutes of Health's picture
NIH
07/19/2017 - 17:04
Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Mylan's picture
Mylan
07/13/2017 - 15:49
FDA Oncologic Drugs Advisory Committee Unanimously Recommends Approval of Mylan and Biocon's Proposed Biosimilar Trastuzumab
Mylan's picture
Mylan
06/10/2017 - 11:44
Mylan and Biocon Present Clinical Data on Insulin Glargine at the American Diabetes Association's 77th Scientific Sessions
Mylan's picture
Mylan
06/02/2017 - 10:01
Mylan Launches Generic Reclast Injection
Mylan's picture
Mylan
06/02/2017 - 08:47
Mylan Launches Generic Azilect Tablets
Mylan's picture
Mylan
05/30/2017 - 03:46
Merck Receives FDA Approval of ISENTRESS HD (raltegravir), a New Once-Daily Option, in Combination with Other Antiretroviral Agents, for the Treatment of HIV-1 Infection in Appropriate Patients
Merck's picture
Merck
05/29/2017 - 08:43
Toward an HIV Cure: Pitt Team Develops Test to Detect Hidden Virus
University of Pittsburgh Medical Center's picture
UPMC
05/26/2017 - 14:18
UCLA leading $20 million effort to reduce HIV among youth
University of California Los Angeles's picture
UCLA
05/23/2017 - 06:14
Theravance Biopharma and Mylan Report Additional Phase 3 Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS
Mylan's picture
Mylan
05/18/2017 - 10:24
2017 AIDS Vaccine Awareness Day
Ragon Institute's picture
Ragon Institute
05/18/2017 - 08:20
NIH statement on HIV Vaccine Awareness Day - 2017
National Institutes of Health's picture
NIH
05/17/2017 - 06:55
Theravance Biopharma and Mylan to Present Additional Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS
Mylan's picture
Mylan
05/16/2017 - 09:45
Mylan Honors National Women's Health Week to Empower Women to Take Control of Their Health
Mylan's picture
Mylan
04/20/2017 - 12:34
Mylan Launches Generic Trilafon Tablets
Mylan's picture
Mylan
04/05/2017 - 05:00
Cancer Burden May Be Changing for People Living With HIV
American Association for Cancer Research's picture
American Associ...
03/29/2017 - 14:41
Mylan Completes Acquisition of Cold-EEZE Brand
Mylan's picture
Mylan
03/20/2017 - 10:48
Mylan Receives Tentative Approval for "TLE400" Under PEPFAR
Mylan's picture
Mylan
03/13/2017 - 11:15
Mylan Launches Generic Aromasin Tablets
Mylan's picture
Mylan